CIK 0001843762
EQRX EQRx, Inc.
Insider trading from SEC Form 4. Last filing Nov 14, 2023.
In brief
EQRx, Inc. (EQRX) has 14 SEC Form 4 filings on file from 14 insiders, the latest filed on Nov 14, 2023. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
14
with a Form 4 at this company
Signals
Open-market buys and sells at EQRx, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The newest 50 of 64 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 9, 2023 | Eli Casdin owner | JOther Common Stockindirect: See footnote | -8,659,372 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | Eli Casdin owner | JOther Common Stockindirect: See footnote | -30,214,934 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | Eli Casdin owner | JOther Common Stockindirect: See footnote | -3,824,572 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | Eli Casdin owner | JOther Common Stockindirect: See footnote | -5,488,164 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | Eli Casdin owner | JOther Warrants to purchase Class A Common Stock (right to buy)derivativeindirect: See footnote | -8,110,001 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | Eli Casdin owner | JOther Earn-out Sharesderivativeindirect: See footnote | -3,472,300 | - | - | 0 | Nov 14, 2023 |
| Nov 9, 2023 | Eli Casdin owner | JOther Earn-out Sharesderivativeindirect: See footnote | -526,674 | - | - | 0 | Nov 14, 2023 |
| Nov 9, 2023 | Eli Casdin owner | JOther Earn-out Sharesderivativeindirect: See footnote | -755,766 | - | - | 0 | Nov 14, 2023 |
| Nov 9, 2023 | Eli Casdin owner | JOther Stock Option (Right to Buy)derivative | -101,010 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | Melanie Nallicheri Chief Executive Officer | MOption exercise Common Stock | +626,999 | $2.21 | $1.4M | 6,306,246 | Nov 9, 2023 |
| Nov 9, 2023 | AH Equity Partners LSV I, L.L.C. owner | UTender of shares Common Stockindirect: By AD Holdings, LLC | -12,264 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Jorge Conde director | DDisposition to issuer Common Stockindirect: By AH Bio Fund II, L.P. | -17,438,465 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. owner | UTender of shares Common Stockindirect: By AD Holdings, LLC | -12,264 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Amy Abernethy director | DDisposition to issuer Common Stock | -200,000 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Clive Meanwell director | DDisposition to issuer Stock Option (Right to Buy)derivative | -313,500 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Paul L Berns director | DDisposition to issuer Common Stock | -627,000 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Alexis Borisy Executive Chairman | DDisposition to issuer Common Stock | -18,810,000 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Dina Ciarimboli General Counsel and Secretary | DDisposition to issuer Common Stock | -731,750 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Samuel J. Merksamer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,010 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Krishna Yeshwant director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,010 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Kathryn E Giusti director | DDisposition to issuer Stock Option (Right to Buy)derivative | -159,286 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Sandra Horning director | DDisposition to issuer Common Stock | -470,250 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. owner | UTender of shares Common Stockindirect: By AH Bio Fund II, L.P. | -17,438,465 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Sandra Horning director | DDisposition to issuer Stock Option (Right to Buy)derivative | -313,500 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Dina Ciarimboli General Counsel and Secretary | DDisposition to issuer Stock Option (Right to Buy)derivative | -156,750 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Amy Abernethy director | DDisposition to issuer Stock Option (Right to Buy)derivative | -389,223 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Clive Meanwell director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,010 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Jorge Conde director | DDisposition to issuer Common Stockindirect: By AH Bio Fund III, L.P. | -19,192,015 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | AH Equity Partners LSV I, L.L.C. owner | UTender of shares Common Stockindirect: By AH Bio Fund II, L.P. | -17,438,465 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Melanie Nallicheri Chief Executive Officer | DDisposition to issuer Common Stock | -6,306,246 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Alexis Borisy Executive Chairman | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,194,499 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Paul L Berns director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,010 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Kathryn E Giusti director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,010 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Dina Ciarimboli General Counsel and Secretary | DDisposition to issuer Stock Option (Right to Buy)derivative | -575,000 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Jorge Conde director | DDisposition to issuer Common Stockindirect: By Andreessen Horowitz LSV Fund I, L.P. | -11,433,677 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Paul L Berns director | DDisposition to issuer Earn-out Sharesderivative | -86,344 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | AH Equity Partners LSV I, L.L.C. owner | UTender of shares Common Stockindirect: By AH Bio Fund III, L.P. | -19,192,015 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Clive Meanwell director | DDisposition to issuer Earn-out Sharesderivative | -43,172 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Alexis Borisy Executive Chairman | DDisposition to issuer Earn-out Sharesderivative | -2,892,491 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Melanie Nallicheri Chief Executive Officer | DDisposition to issuer Common Stockindirect: By MIN 2020 LLC | -3,851,147 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Kathryn E Giusti director | DDisposition to issuer Earn-out Sharesderivative | -21,934 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Sandra Horning director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,010 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. owner | UTender of shares Common Stockindirect: By AH Bio Fund III, L.P. | -19,192,015 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. owner | UTender of shares Common Stockindirect: By Andreessen Horowitz LSV Fund I, L.P. | -11,433,677 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Dina Ciarimboli General Counsel and Secretary | DDisposition to issuer Earn-out Sharesderivative | -43,172 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Jorge Conde director | DDisposition to issuer Common Stockindirect: By Andreessen Horowitz LSV Fund II, L.P. | -5,000,000 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Melanie Nallicheri Chief Executive Officer | MOption exercise Stock Option (Right to Buy)derivative | -626,999 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Sandra Horning director | DDisposition to issuer Earn-out Sharesderivative | -107,929 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | AH Equity Partners LSV I, L.L.C. owner | UTender of shares Common Stockindirect: By Andreessen Horowitz LSV Fund I, L.P. | -11,433,677 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | Jorge Conde director | DDisposition to issuer Earn-out Sharesderivativeindirect: By AH Bio Fund II, L.P. | -2,401,418 | - | - | 0 | Nov 9, 2023 |
50 of 64 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- AH Equity Partners Bio II, L.L.C.owner
- AH Equity Partners LSV I, L.L.C.owner
- Amy Abernethydirector
- Paul L Bernsdirector, officer, owner
- Alexis BorisyExecutive Chairman
- Eli Casdindirector, owner
- Dina CiarimboliGeneral Counsel and Secretary
- Jorge Condedirector
- Kathryn E Giustidirector
- Sandra Horningdirector
- Clive Meanwelldirector, chair, officer
- Samuel J. Merksamerdirector
- Melanie NallicheriChief Executive Officer
- Krishna Yeshwantdirector, owner
Questions about EQRX
Answered from the filings on this page, as of the latest one.
Are insiders buying EQRX?
No. In the last 90 days no insider at EQRx, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade EQRX on the open market?
No open-market trade has been scored at EQRx, Inc.. The latest Form 4 on file was filed on Nov 14, 2023 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at EQRx, Inc.?
14 people have filed a Form 4 at EQRx, Inc., among them AH Equity Partners Bio II, L.L.C. (10% owner), AH Equity Partners LSV I, L.L.C. (10% owner), Amy Abernethy (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.